Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127959411 | 12795941 | 1 | I | 20160910 | 20160927 | 20160929 | 20160929 | EXP | CO-ABBVIE-16P-036-1741158-00 | ABBVIE | 85.74 | YR | M | Y | 0.00000 | 20160929 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127959411 | 12795941 | 1 | PS | ZEMPLAR | PARICALCITOL | 1 | Oral | UNKNOWN | 21606 | 1 | UG | CAPSULE | QD | ||||||
| 127959411 | 12795941 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 4 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 5 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 6 | C | QUETIAPINE. | QUETIAPINE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 10 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 127959411 | 12795941 | 11 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127959411 | 12795941 | 1 | Hyperparathyroidism secondary |
| 127959411 | 12795941 | 2 | Product used for unknown indication |
| 127959411 | 12795941 | 3 | Product used for unknown indication |
| 127959411 | 12795941 | 4 | Product used for unknown indication |
| 127959411 | 12795941 | 5 | Product used for unknown indication |
| 127959411 | 12795941 | 6 | Product used for unknown indication |
| 127959411 | 12795941 | 7 | Product used for unknown indication |
| 127959411 | 12795941 | 8 | Product used for unknown indication |
| 127959411 | 12795941 | 10 | Product used for unknown indication |
| 127959411 | 12795941 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127959411 | 12795941 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127959411 | 12795941 | Cardiac failure | |
| 127959411 | 12795941 | Pneumonia | |
| 127959411 | 12795941 | Pulmonary oedema | |
| 127959411 | 12795941 | Renal impairment | |
| 127959411 | 12795941 | Respiratory distress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127959411 | 12795941 | 1 | 20150424 | 20160910 | 0 |